Annual Information Update

RNS Number : 9494E

Hikma Pharmaceuticals Plc

14 April 2011

 



Annual Information Update

LONDON, 14 April 2011.  In accordance with Prospectus Rule 5.2, Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK) sets out below a summary of the information which has been published or made available to the public over the period. The information referred to in this Update was up to date at the time the information was published, but some information may now be out of date.

Stock Exchange Announcements

Announcements made by the Company via RNS, a Regulatory Information Service, may be viewed and downloaded from the Company's market news section on the London Stock Exchange website at (http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-prices.htm) or from the press releases page on the Company's website at (http://www.hikma.com/investorrelations/rns/). The Stock Exchange announcements made during the period were:

Date of Announcement	Headline of Announcement
13/04/2011	Director/PDMR Shareholding
11/04/2011	Total Voting Rights
11/04/2011	Blocklisting Interim Review
04/04/2011	Director/PDMR Shareholding
18/03/2011	Director/PDMR Shareholding
16/03/2011	Preliminary Results
02/03/2011	Total Voting Rights
08/02/2011	Total Voting Rights
03/02/2011	Holding(s) in Company
24/01/2011	Appointments
12/01/2011	Total Voting Rights
12/01/2011	Director/PDMR Shareholding
10/01/2011	Director/PDMR Shareholding
10/01/2011	Director/PDMR Shareholding
05/01/2011	Total Voting Rights
16/12/2010	Director/PDMR Shareholding
06/12/2010	Director/PDMR Shareholding
01/12/2010	Director/PDMR Shareholding
12/11/2010	Interim Management Statement
09/11/2010	Director/PDMR Shareholding
05/11/2010	Total Voting Rights
04/11/2010	Director/PDMR Shareholding
02/11/2010	Director/PDMR Shareholding
29/10/2010	Acquisition
18/10/2010	Product Update
15/10/2010	Block Listing for Share Schemes
04/10/2010	Total Voting Rights
04/10/2010	Blocklisting Interim Review
01/10/2010	Company Update
06/09/2010	Total Voting Rights
26/08/2010	Interim Results
04/08/2010	Voting Rights and Capital
02/08/2010	Annual Information Update

All of the above announcements were also made by the Company via the NasdaqDubai stock exchange CANDI system.  These announcements may be viewed and downloaded from the NasdaqDubai website (www.candi.nasdaq.com). 

Documents filed with the Financial Services Authority

The Company has filed the following documents with the Financial Services Authority ("FSA") visa the National Storage Mechanism over the previous 12 months.  These documents are available at http://www.hemscott.com/nsm.do or at the Company's registered office.

Date	Document
6 April 2011	Annual Report and Accounts 2010
6 April 2011	Notice of 2011 Annual General Meeting
14 April 2011	Proxy forms for the 2011 Annual General Meeting

Documents filed with Companies House

The Company submitted filings to the Registrar of Companies in England and Wales as detailed in the table below. 

Date Filed	Form	Description
08/02/2011	SH01	31/01/11 Statement of Capital GBP 19356098
14/01/2011	SH01	31/12/10 Statement of Capital GBP 19351698
05/01/2011	SH01	30/11/10 Statement of Capital GBP 19344848
11/11/2010	SH01	31/10/10 Statement of Capital GBP 19340139
18/10/2010	SH01	30/09/10 Statement of Capital GBP 19338739
09/09/2010	AR01	08/09/10 Full List
02/09/2010	CH01	Director's Change of Particulars / Samih Darwazah / 01/09/2010
02/09/2010	CH01	Director's Change of Particulars / Ali Al Husry / 01/09/2010
02/09/2010	CH01	Director's Change of Particulars / Mazen Samih Darwazeh / 01/09/2010
02/09/2010	CH01	Director's Change of Particulars / Ronald Lane Goode / 01/09/2010
01/09/2010	CH01	Director's Change of Particulars / Michael Richard Dwyer Ashton / 01/09/2010
01/09/2010	CH01	Director's Change of Particulars / Said Samih Darwazah / 01/09/2010
01/09/2010	CH01	Director's Change of Particulars / Breffni John Byrne / 01/09/2010
01/09/2010	CH01	Director's Change of Particulars / Sir David Rowe Ham / 01/09/2010
01/09/2010	CH03	Secretary's Change of Particulars / Henry James Knowles / 01/09/2010
23/08/2010	SH01	30/06/10 Statement of Capital GBP 19336649

Copies of all these documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a registered user, they may be viewed and downloaded using Companies House Direct at www.direct.companieshouse.gov.uk.

Further Information

Further information about Hikma Pharmaceuticals PLC can be found at our website www.hikma.com. Copies of all documents can be obtained from the Company at the registered office which is located at 13 Hanover Square, London W1S 1HW.

Henry Knowles

Company Secretary

14 April 2011

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC
Henry Knowles Company Secretary	[phone]
Susan Ringdal Investor Relations Director	[phone]
Financial Dynamics
Ben Atwell/ Julia Phillips		[phone]
Jonathan Birt/ Matthew Cole

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products.  Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics".  Hikma's operations are based principally in the Middle East and North Africa ("MENA") region, where it is a market leader and sells across 17 countries, the United States and Europe.  In 2010, the Group achieved revenues of $731 million (2009 $637 million) and profit attributable to shareholders was $99 million (2009 $78 million).  For news and other information, please visit www.hikma.com.

 

END

 

 

AIUEZLFFFZFBBBL